EquityFlow
›
Companies
› Nanoligent
Nanoligent
Biotech
· Barcelona, ES
Sviluppa nanofarmaci mirati per il trattamento del cancro.
Funding history
Date
Round
Amount
Oct 2025
Funding round
Nanoligent raised €12 million led by Inveready for its precision oncology nanodrugs.
$13.9M
Investors
CDTI
Clave Capital
Inveready
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →